General Information of the Protein
Protein ID
PT01138
Protein Name
Thymidine kinase, cytosolic
Gene Name
TK1
Sequence
MSCINLPTVLPGSPSKTRGQIQVILGPMFSGKSTELMRRVRRFQIAQYKCLVIKYAKDTRYSSSFCTHDRNTMEALPACLLRDVAQEALGVAVIGIDEGQFFPDIVEFCEAMANAGKTVIVAALDGTFQRKPFGAILNLVPLAESVVKLTAVCMECFREAAYTKRLGTEKEVEVIGGADKYHSVCRLCYFKKASGQPAGPDNKENCPVPGKPGEAVAARKLFAPQQILQCSPAN
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Transferase
Function
Cell-cycle-regulated enzyme of importance in nucleotide metabolism (PubMed:9575153). Catalyzes the first enzymatic step in the salvage pathway converting thymidine into thymidine monophosphate (PubMed:22385435). Transcriptional regulation limits expression to the S phase of the cell cycle and transient expression coincides with the oscillation in the intracellular dTTP concentration (Probable). Also important for the activation of anticancer and antiviral nucleoside analog prodrugs such as 1-b-d-arabinofuranosylcytosine (AraC) and 3c-azido-3c-deoxythymidine (AZT) (PubMed:22385435).
    Show/Hide
Uniprot ID
Primary ID:
P04183

Secondarily ID:
B2RC58
Q969V0
Q9UMG9
    Show/Hide
Ensembl ID
ENSG00000167900
HGNC ID
HGNC:11830
Subcellular Location
Cytoplasm
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000057 , Vero
Compound ID Compound Name Compound Formula
CP0172903
FIALURIDINE
   Show/Hide
C9H10FIN2O5
 1
1
Km = 53000 nM
   TI
   LI
   LO
   TS
CP0097715
1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
   Show/Hide
C10H13FN2O5
 1
1
Km = 60000 nM
   TI
   LI
   LO
   TS
CP0104249
5-ethyl-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
   Show/Hide
C11H15FN2O5
 1
1
Km = 3154700 nM
   TI
   LI
   LO
   TS
CP0689145
2-Amino-9-(2-hydroxy-ethoxymethyl)-5,9-dihydro-purin-6-one (ACV)
   Show/Hide
C8H11N5O3
 1
1
Km > 4920000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0041607
(AZT) 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione
   Show/Hide
C10H13N5O4
 4
1 IC50 = 3000 nM
2 Ki = 2900 nM
3 Ki = 7000 nM
4 Km = 3500 nM
CP0104249
5-ethyl-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
   Show/Hide
C11H15FN2O5
 2
1 Ki = 90 nM
2 Ki = 440 nM
CP0172903
FIALURIDINE
   Show/Hide
C9H10FIN2O5
 2
1 Ki = 140 nM
2 Ki = 950 nM
CP0097715
1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
   Show/Hide
C10H13FN2O5
 2
1 Ki = 180 nM
2 Ki = 1400 nM
CP0049058
dT
   Show/Hide
C10H14N2O5
 10
1 Ki = 200 nM
2 Ki = 2000 nM
3 Km = 290 nM
4 Km = 660 nM
5 Km = 1000 nM
6 Km = 1800 nM
7 Km = 2800 nM
8 Km = 3000 nM
9 Km = 4000 nM
10 Km = 49000 nM
CP0689145
2-Amino-9-(2-hydroxy-ethoxymethyl)-5,9-dihydro-purin-6-one (ACV)
   Show/Hide
C8H11N5O3
 1
1 Ki = 45000 nM
CP0077024
2-Amino-9-(2-hydroxy-ethoxymethyl)-5,9-dihydro-purin-6-one
   Show/Hide
C8H11N5O3
 1
1 Km = 1500 nM
CP0736210
SID124893542
   Show/Hide
C8H11N5O3
 1
1 Km = 12800 nM
Clinical Information about the Protein
Target 1 ( Thymidine kinase 1 (TK1) )
Target Type Successful Target
Disease 4 Target-related Diseases  4
1 Acute myeloid leukaemia [ICD-11: 2A60]
2 Human immunodeficiency virus infection [ICD-11: 1C62]
3 Pancreatic cancer [ICD-11: 2C10]
4 Cardiovascular disease [ICD-11: BA00-BE2Z]
Approved Drug(s) 2 Approved Drugs  2
1 DEOXYCYTIDINE Approved
Acute myeloid leukaemia
2 Penciclovir Approved
Human immunodeficiency virus infection
Clinical Trial Drug(s) 2 Clinical Trial Drugs  2
1 RP101 Phase 2/3
Pancreatic cancer
2 Rilapladib Phase 1
Cardiovascular disease